Cytokinetics
CYTK
$65.34
Share price
0.83%
Change (1 day)
74.71%
Change (1 year)
Categories
EPS for Cytokinetics (CYTK)
EPS in 2023 (TTM): -$5.69
According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is -$5.69. In 2022 the company made an earnings per share (EPS) of -$4.25 a decrease over its 2021 EPS that were of -$2.83.
EPS history for Cytokinetics from 2003 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$5.69 | 33.88% |
| 2022 | -$4.25 | 50.18% |
| 2021 | -$2.83 | 40.8% |
| 2020 | -$2.01 | -4.74% |
| 2019 | -$2.11 | 8.21% |
| 2018 | -$1.95 | -24.12% |
| 2017 | -$2.57 | -776.32% |
| 2016 | $0.38 | -139.18% |
| 2015 | -$0.97 | 125.58% |
| 2014 | -$0.43 | -67.67% |
| 2013 | -$1.33 | -44.58% |
| 2012 | -$2.40 | -44.95% |
| 2011 | -$4.36 | -6.84% |
| 2010 | -$4.68 | -290.24% |
| 2009 | $2.46 | -135.96% |
| 2008 | -$6.84 | 10.68% |
| 2007 | -$6.18 | -33.97% |
| 2006 | -$9.36 | 5.41% |
| 2005 | -$8.88 | -60.64% |
| 2004 | -$22.56 | -77.21% |
| 2003 | -$99.00 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $14.15 | -348.68% | 🇺🇸 USA |
 Trevena TRVN | -$4.48 | -21.27% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $1.57 | -127.59% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$9.78 | 71.84% | 🇺🇸 USA |
 Array Technologies ARRY | $0.51 | -108.96% | 🇺🇸 USA |